Hospital readmission following transcatheter aortic valve implantation in the real world

Zahn, 2011, Transcatheter aortic valve implantation: first results from a multi-centre real-world registry, Eur. Heart J., 32, 198, 10.1093/eurheartj/ehq339 Moat, 2011, Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry, J. Am. Coll. Cardiol., 58, 2130, 10.1016/j.jacc.2011.08.050 Webb, 2011, Percutaneous transarterial aortic valve implantation: what do we know?, Eur. Heart J., 32, 140, 10.1093/eurheartj/ehq453 Yamamoto, 2012, Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥90 years versus <90 years, Am. J. Cardiol., 110, 1156, 10.1016/j.amjcard.2012.05.058 Yamamoto, 2014, Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry, Ann. Thorac. Surg., 97, 29, 10.1016/j.athoracsur.2013.07.100 Buellesfeld, 2012, Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry, J. Invasive Cardiol., 24, 531 Nombela-Franco, 2015, Incidence, causes, and predictors of early (≤30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement, JACC Cardiovasc. Interv., 8, 1748, 10.1016/j.jcin.2015.07.022 Nishimura, 2014, AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines, J. Am. Coll. Cardiol., 63, e57, 10.1016/j.jacc.2014.02.536 Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur. Heart J., 33, 2451, 10.1093/eurheartj/ehs109 Webb, 2007, Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis, Circulation, 116, 755, 10.1161/CIRCULATIONAHA.107.698258 Grube, 2007, Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome, J. Am. Coll. Cardiol., 50, 69, 10.1016/j.jacc.2007.04.047 Walther, 2009, Transapical aortic valve implantation: step by step, Ann. Thorac. Surg., 87, 276, 10.1016/j.athoracsur.2008.08.017 Holmes, 2015, Clinical outcomes at 1 year following transcatheter aortic valve replacement, JAMA, 313, 1019, 10.1001/jama.2015.1474 Kolte, 2017, Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the nationwide readmissions database, Circ. Cardiovasc. Interv., 10, 10.1161/CIRCINTERVENTIONS.116.004472 Hannan, 2015, Thirty-day readmissions after transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis in New York state, Circ. Cardiovasc. Interv., 8, 10.1161/CIRCINTERVENTIONS.115.002744 Aizawa, 2015, Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database, BMC Cardiovasc. Disord., 15, 134, 10.1186/s12872-015-0127-9 Koyama, 2015, Early and mid-term results of isolated aortic valve replacement for aortic stenosis in octogenarians, Gen. Thorac. Cardiovasc. Surg., 63, 216, 10.1007/s11748-014-0498-3 Oguri, 2015, Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry, EuroIntervention, 10, e1, 10.4244/EIJV10I9A183 Hioki, 2017, Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding, Heart, 103, 361, 10.1136/heartjnl-2016-309735 Liao, 2017, Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis, EuroIntervention, 12, 2067, 10.4244/EIJ-D-15-00254 Yamamoto, 2013, Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation, JACC Cardiovasc. Interv., 6, 479, 10.1016/j.jcin.2013.02.007 Yamamoto, 2017, Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese multicenter OCEAN-TAVI registry), Am. J. Cardiol., 119, 770, 10.1016/j.amjcard.2016.11.019 Saji, 2017, Impact of frailty markers for unplanned hospital readmission following transcatheter aortic valve implantation, Circ. J., 70, B62 Lefevre, 2011, One year follow-up of the multi-centre European PARTNER transcatheter heart valve study, Eur. Heart J., 32, 148, 10.1093/eurheartj/ehq427 Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N. Engl. J. Med., 366, 1686, 10.1056/NEJMoa1200384